Earnings Ahead

HALO - Halozyme Therapeutics, Inc.

34.2 -0.64 -1.84

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

About

Profile


Headquarters

San Diego, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

HALO



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Halozyme Therapeutics Non-GAAP EPS of $0.82 misses by $0.01, revenue of $230.04M misses by $1.1M
  • Halozyme Therapeutics Q4 2023 Earnings Preview
  • J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma
  • EU okays Takeda's Hyqvia co-formulated with Halozyme's Enhanze
  • Lipocine licenses Tlando testosterone therapy to Verity Pharma
  • Regeneron’s high-dose Eylea, argenx’s Vyvgart injectable among latest approvals in Japan
  • Halozyme’s early 2023 results indicate a mixed performance
  • Halozyme gains as U.S. and EU clear Enhanze-based products
  • Top overweight stocks with high free cash flow and EPS growth - MS
  • JNJ multiple myeloma therapy outperforms standard of care by 58%
  • argenx slips as autoimmune disorder therapy fails in pivotal trial
  • Teva gains U.S. approval for generic version of osteoporosis injection
  • Argenx Vyvgart injectable granted EU nod for myasthenia gravis
  • Halozyme Therapeutics Non-GAAP EPS of $0.75 beats by $0.04, revenue of $216M in-line
  • Halozyme, Acumen enter collaboration for Alzheimer's drug candidate
  • Earnings week ahead: Disney, AMC, Plug Power, Lucid, Realty Income and more
  • Halozyme Therapeutics Q3 2023 Earnings Preview
  • Bristol Myers succeeds in Phase 3 trial for subcutaneous Opdivo
  • Roche granted U.K. approval for subcutaneous Tecentriq
  • Halozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.10, revenue of $221.04M beats by $21.09M
PEERS
/XLV

XLV

Date Price Open High Low Vol Change
Jan 29 55.83 56.03
56.74
55.12
841K -0.3%
Jan 28 56 55.97
56.82
55.66
1.2M 0.25%
Jan 27 55.86 55.69
57.25
55.24
914K 0.16%
Jan 24 55.77 55.29
56.08
54.97
732K 0.25%
Jan 23 55.63 55.22
55.87
54.96
935K 0.63%
 
Jan 22 55.28 55.79
56
54.99
1.2M -1.18%
Jan 21 55.94 55.1
56.39
54.88
1.2M 2.08%
Jan 17 54.8 55.66
55.73
54.76
942K -1.03%
Jan 16 55.37 54.64
55.79
54.64
1.6M 1.58%
Jan 15 54.51 54.39
55.3
54.05
2.0M 1.26%
Jan 14 53.83 54.74
54.87
53.26
1.4M -0.57%
Jan 13 54.14 52.65
54.84
52.23
2.0M 2.54%
Jan 10 52.8 53.95
53.99
52.66
2.1M -1.79%
Jan 8 53.76 54.12
55
51.91
2.7M 5.02%
Jan 7 51.19 51
51.73
50.35
1.8M 1.35%
Jan 6 50.51 47.75
50.81
47.75
1.9M 5.80%
Jan 3 47.74 48.2
48.53
47.52
993K -0.56%
Jan 2 48.01 48.23
49
47.86
1.2M 0.42%
Dec 31, 2024 47.81 48.2
48.72
47.72
843K -0.38%
Dec 30, 2024 47.99 48.65
48.8
47.65
892K -0.29%
Dec 27, 2024 48.13 47.6
48.26
47.56
946K 0.21%
Dec 26, 2024 48.03 47.47
48.24
46.99
762K 1.03%
Dec 24, 2024 47.54 47.25
47.63
46.76
309K 0.81%
Dec 23, 2024 47.16 46.77
47.34
46.26
1.5M 0.43%
Dec 20, 2024 46.96 47.03
48.21
46.88
4.8M -0.76%
Dec 19, 2024 47.32 46.94
48.11
46.9
1.8M 1.02%
Dec 18, 2024 46.84 48.66
49.6
46.45
1.9M -3.62%
Dec 17, 2024 48.6 47.58
48.82
47.54
1.3M 1.19%
Dec 16, 2024 48.03 48.1
48.88
47.69
2.2M 0.06%
Dec 13, 2024 48 47.32
48.31
47.31
932K 0.36%
Dec 12, 2024 47.83 47.39
48.64
47.39
928K 0.93%
Dec 11, 2024 47.39 49.24
49.35
47.08
1.2M -3.4%
Dec 10, 2024 49.06 49.26
49.79
48.32
1.1M 0%
Dec 9, 2024 49.06 48.2
49.27
47.84
867K 1.36%
Dec 6, 2024 48.4 48.4
49.05
48.14
906K 0.71%
Dec 5, 2024 48.06 48.1
48.64
47.36
1.0M -1.13%
Dec 4, 2024 48.61 48.76
49.08
48.43
786K 0.27%
Dec 3, 2024 48.48 48.56
48.83
47.79
1.2M -0.23%
Dec 2, 2024 48.59 48.12
48.78
47.4
1.3M 0.81%
Nov 29, 2024 48.2 48.3
48.81
48.12
721K -0.56%
Nov 27, 2024 48.47 47.78
48.74
47.37
963K 1.42%
Nov 26, 2024 47.79 47.53
48.17
46.27
1.4M 0%
Nov 25, 2024 47.79 49.51
50
47.01
3.2M -2.47%
Nov 22, 2024 49 48.93
49.57
46.21
4.5M 7.22%
Nov 21, 2024 45.7 45.85
46.12
44.8
1.3M -0.13%
Nov 20, 2024 45.76 44.57
46.2
44.1
1.9M 2.12%
Nov 19, 2024 44.81 43.81
45.3
42.65
3.8M 5.26%
Nov 18, 2024 42.57 45.66
45.71
42.01
5.5M -6.75%
Nov 15, 2024 45.65 48.81
49.64
45.63
7.2M -15.4%
Nov 14, 2024 53.96 58.25
59.8
53.84
3.2M -7.93%
Nov 13, 2024 58.61 59.79
60.37
58.46
831K -1.68%
Nov 12, 2024 59.61 61.08
62.02
59.24
1.5M -2.42%
Nov 11, 2024 61.09 61.13
62.13
60.55
1.5M 0.18%
Nov 8, 2024 60.98 59.65
61.19
59.14
1.1M 2.23%
Nov 7, 2024 59.65 60.66
60.95
58.76
1.1M -1.62%
Nov 6, 2024 60.63 60.55
61.49
58.01
1.5M 3.25%
Nov 5, 2024 58.72 58
58.74
57.08
1.1M 0.43%
Nov 4, 2024 58.47 56.82
59.39
56.82
2.1M 2.31%
Nov 1, 2024 57.15 55.65
57.62
52.56
3.4M 13.01%
Oct 31, 2024 50.57 50.56
51.21
50.01
1.9M 0%